Pulmonary nodular ground-glass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions?

MLA

Park CM, et al. “Pulmonary Nodular Ground-Glass Opacities in Patients with Extrapulmonary Cancers: What Is Their Clinical Significance and How Can We Determine Whether They Are Malignant or Benign Lesions?” CHEST, vol. 133, no. 6, June 2008, pp. 1402–09. EBSCOhost, https://doi.org/10.1378/chest.07-2568.

APA

Park CM, Goo JM, Kim TJ, Lee HJ, Lee KW, Lee CH, Kim YT, Kim KG, Lee HY, Park EA, Im JG, Park, C. M., Goo, J. M., Kim, T. J., Lee, H. J., Lee, K. W., Lee, C. H., Kim, Y. T., Kim, K. G., & Lee, H. Y. (2008). Pulmonary nodular ground-glass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions? CHEST, 133(6), 1402–1409. https://doi.org/10.1378/chest.07-2568

Chicago

Park CM, Goo JM, Kim TJ, Lee HJ, Lee KW, Lee CH, Kim YT, et al. 2008. “Pulmonary Nodular Ground-Glass Opacities in Patients with Extrapulmonary Cancers: What Is Their Clinical Significance and How Can We Determine Whether They Are Malignant or Benign Lesions?” CHEST 133 (6): 1402–9. doi:10.1378/chest.07-2568.